Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029384096> ?p ?o ?g. }
- W2029384096 endingPage "230" @default.
- W2029384096 startingPage "222" @default.
- W2029384096 abstract "Two series of novel ether analogs of the sigma (σ) receptor ligand 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503) have been prepared. In one series, the alkyl portion of the 4-methoxy group was replaced with allyl, propyl, bromoethyl, benzyl, phenethyl, and phenylpropyl moieties. In the second series, the 3,4-dimethoxy was replaced with cyclic methylenedioxy, ethylenedioxy and propylenedioxy groups. These ligands, along with 4-O-des-methyl SA4503, were evaluated for σ1 and σ2 receptor affinity, and compared to SA4503 and several known ether analogs. SA4503 and a subset of ether analogs were also evaluated for dopamine transporter (DAT) and serotonin transporter (SERT) affinity. The highest σ1 receptor affinities, Ki values of 1.75–4.63 nM, were observed for 4-O-des-methyl SA4503, SA4503 and the methylenedioxy analog. As steric bulk increased, σ1 receptor affinity decreased, but only to a point. Allyl, propyl and bromoethyl substitutions gave σ1 receptor Ki values in the 20–30 nM range, while bulkier analogs having phenylalkyl, and Z- and E-iodoallyl, ether substitutions showed higher σ1 affinities, with Ki values in the 13–21 nM range. Most ligands studied exhibited comparable σ1 and σ2 affinities, resulting in little to no subtype selectivity. SA4503, the fluoroethyl analog and the methylenedioxy congener showed modest six- to fourteen-fold selectivity for σ1 sites. DAT and SERT interactions proved much more sensitive than σ receptor interactions to these structural modifications. For example, the benzyl congener (σ1 Ki = 20.8 nM; σ2 Ki = 16.4 nM) showed over 100-fold higher DAT affinity (Ki = 121 nM) and 6-fold higher SERT affinity (Ki = 128 nM) than the parent SA4503 (DAT Ki = 12650 nM; SERT Ki = 760 nM). Thus, ether modifications to the SA4503 scaffold can provide polyfunctional ligands having a broader spectrum of possible pharmacological actions." @default.
- W2029384096 created "2016-06-24" @default.
- W2029384096 creator A5018939644 @default.
- W2029384096 creator A5024310449 @default.
- W2029384096 creator A5027800128 @default.
- W2029384096 creator A5064804495 @default.
- W2029384096 creator A5064934178 @default.
- W2029384096 creator A5076368300 @default.
- W2029384096 date "2015-01-01" @default.
- W2029384096 modified "2023-10-18" @default.
- W2029384096 title "Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): Effects on binding affinity and selectivity for sigma receptors and monoamine transporters" @default.
- W2029384096 cites W1479950646 @default.
- W2029384096 cites W1889531646 @default.
- W2029384096 cites W1923388221 @default.
- W2029384096 cites W1960147035 @default.
- W2029384096 cites W1967185984 @default.
- W2029384096 cites W1970653703 @default.
- W2029384096 cites W1980337077 @default.
- W2029384096 cites W1981373150 @default.
- W2029384096 cites W1994224293 @default.
- W2029384096 cites W1996144471 @default.
- W2029384096 cites W1999798503 @default.
- W2029384096 cites W2003532781 @default.
- W2029384096 cites W2003888864 @default.
- W2029384096 cites W2010793728 @default.
- W2029384096 cites W2013671530 @default.
- W2029384096 cites W2014315340 @default.
- W2029384096 cites W2015524948 @default.
- W2029384096 cites W2021301090 @default.
- W2029384096 cites W2021583585 @default.
- W2029384096 cites W2025846044 @default.
- W2029384096 cites W2026692772 @default.
- W2029384096 cites W2028046413 @default.
- W2029384096 cites W2030427748 @default.
- W2029384096 cites W2038550216 @default.
- W2029384096 cites W2039274171 @default.
- W2029384096 cites W2047511397 @default.
- W2029384096 cites W2048914434 @default.
- W2029384096 cites W2049985924 @default.
- W2029384096 cites W2050666972 @default.
- W2029384096 cites W2053780933 @default.
- W2029384096 cites W2055397294 @default.
- W2029384096 cites W2056009862 @default.
- W2029384096 cites W2056028912 @default.
- W2029384096 cites W2066253469 @default.
- W2029384096 cites W2067340043 @default.
- W2029384096 cites W2067996345 @default.
- W2029384096 cites W2070194801 @default.
- W2029384096 cites W2074631079 @default.
- W2029384096 cites W2083851794 @default.
- W2029384096 cites W2089351812 @default.
- W2029384096 cites W2090267247 @default.
- W2029384096 cites W2090729149 @default.
- W2029384096 cites W2096024512 @default.
- W2029384096 cites W2096465346 @default.
- W2029384096 cites W2101541331 @default.
- W2029384096 cites W2102743964 @default.
- W2029384096 cites W2106858531 @default.
- W2029384096 cites W2118617795 @default.
- W2029384096 cites W2123950263 @default.
- W2029384096 cites W2132216325 @default.
- W2029384096 cites W2141519753 @default.
- W2029384096 cites W2157764621 @default.
- W2029384096 cites W2158663522 @default.
- W2029384096 cites W2158932144 @default.
- W2029384096 cites W2160112975 @default.
- W2029384096 cites W2164789885 @default.
- W2029384096 cites W2166927107 @default.
- W2029384096 cites W2169373325 @default.
- W2029384096 cites W2267842631 @default.
- W2029384096 cites W2331816435 @default.
- W2029384096 cites W2337409655 @default.
- W2029384096 doi "https://doi.org/10.1016/j.bmc.2014.11.007" @default.
- W2029384096 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4274187" @default.
- W2029384096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25468036" @default.
- W2029384096 hasPublicationYear "2015" @default.
- W2029384096 type Work @default.
- W2029384096 sameAs 2029384096 @default.
- W2029384096 citedByCount "9" @default.
- W2029384096 countsByYear W20293840962016 @default.
- W2029384096 countsByYear W20293840962017 @default.
- W2029384096 countsByYear W20293840962019 @default.
- W2029384096 countsByYear W20293840962020 @default.
- W2029384096 countsByYear W20293840962023 @default.
- W2029384096 crossrefType "journal-article" @default.
- W2029384096 hasAuthorship W2029384096A5018939644 @default.
- W2029384096 hasAuthorship W2029384096A5024310449 @default.
- W2029384096 hasAuthorship W2029384096A5027800128 @default.
- W2029384096 hasAuthorship W2029384096A5064804495 @default.
- W2029384096 hasAuthorship W2029384096A5064934178 @default.
- W2029384096 hasAuthorship W2029384096A5076368300 @default.
- W2029384096 hasBestOaLocation W20293840962 @default.
- W2029384096 hasConcept C116569031 @default.
- W2029384096 hasConcept C118792377 @default.
- W2029384096 hasConcept C161790260 @default.
- W2029384096 hasConcept C170493617 @default.
- W2029384096 hasConcept C178790620 @default.
- W2029384096 hasConcept C185592680 @default.